切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2020, Vol. 09 ›› Issue (02) : 86 -89. doi: 10.3877/cma.j.issn.2095-3216.2020.02.008

所属专题: 文献

综述

肾淀粉样变性病的病理诊断与分型、分级的研究进展
陈思羽1, 韩伟霞1, 王晨1,()   
  1. 1. 030001 山西太原,山西医科大学第二医院病理科
  • 收稿日期:2020-01-10 出版日期:2020-04-28
  • 通信作者: 王晨

Research progress in pathological diagnosis, typing and grading of renal amyloidosis

Siyu Chen1, Weixia Han1, Chen Wang1,()   

  1. 1. Department of Pathology, Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Received:2020-01-10 Published:2020-04-28
  • Corresponding author: Chen Wang
  • About author:
    Corresponding author: Wang Chen, Email:
引用本文:

陈思羽, 韩伟霞, 王晨. 肾淀粉样变性病的病理诊断与分型、分级的研究进展[J]. 中华肾病研究电子杂志, 2020, 09(02): 86-89.

Siyu Chen, Weixia Han, Chen Wang. Research progress in pathological diagnosis, typing and grading of renal amyloidosis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(02): 86-89.

淀粉样变性病是由蛋白异常折叠后形成不溶性β-片层构型的淀粉样物发生异常沉积的一类代谢病,肾脏是最常受累的器官之一,诊断主要依赖肾穿刺病理活检。肾淀粉样变性病的临床及病理表现多样,病因学诊断及分型困难,无统一的病理学分级系统,临床缺乏有效的干预治疗。本文将对肾淀粉样变性病的病理表现、诊断及分型分级予以综述,以期为该疾病的诊断、治疗及预后评估提供依据。

Amyloidosis is a disorder caused by extracellular deposition of misfolded proteins in an insoluble beta-pleated physical format. The kidney is a frequent site of amyloid deposition. Diagnosis of renal amyloidosis is based on the renal pathology biopsy. As the clinical features and pathological manifestations of renal amyloidosis are diverse, the diagnosis and typing of renal amyloidosis can sometimes be problematic. There is not a unified pathological grading system and lacks effective clinical interventions for renal amyloidosis. In this manuscript, we described the pathological manifestations, diagnosis, typing, and grading of renal amyloidosis, so as to provide a basis for the diagnosis, treatment, and prognosis evaluation of the disease.

图1 肾淀粉样变性病分型流程图
表1 各型肾淀粉样变性病的临床病理特点
表2 肾淀粉样变性病的病理评分标准
[1]
Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade [J]. Ann Rev Biochem, 2017, 86: 27-68.
[2]
何娅妮,张炜炜. 肾病综合征的流行病学现状 [J]. 中华肾病研究电子杂志,2017, 6(4): 149-153.
[3]
Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee [J]. Amyloid, 2019, 25(4): 1-5.
[4]
Solanki R, Solanki MK, Hemrajani D, et al. A study of detection and comparison of immunofluorescence on formalin-fixed paraffin-embedded tissue with fresh frozen renal biopsy specimen [J]. Saudi J Kidney Dis Transpl, 2019, 30(2): 350-358.
[5]
Aoki M, Kang D, Katayama A, et al. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis [J]. Clin Exp Nephrol, 2018, 22(4): 871-880.
[6]
Cottini F, Bott C, Nadasdy T, et al. A novel APOA1 mutation in a patient with renal amyloidosis: unveiling amyloid by next-generation sequencing [J]. Amyloid, 2019, 26(5): 1-2.
[7]
Masahide Y, Tsuneaki Y, Yoshiki S, et al. Hereditary fibrinogen A α-chain amyloidosis in Asia: clinical and molecular characteristics [J]. Int J Mol Sci, 2018, 19(1): 320.
[8]
Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases [J]. Clin J Am Soc Nephrol, 2013, 8(9): 1515-1523.
[9]
Sen S, Sarsik B. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis standardization of renal amyloid biopsy report [J]. Arch Pathol Lab Med, 2010, 134(4): 532-544.
[10]
Rezk T, Gilbertson JA, Rowczenio D, et al. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis [J]. Nephrol Dial Transplant, 2018, 33(2): 241-247.
[11]
Sethi S, Theis JD. Pathology and diagnosis of renal non-AL amyloidosis [J]. J Nephrol, 2017, 31(3): 343-350.
[12]
Yao Y, Wang SX, ZhangYK, et al. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis [J]. Nephrol Dial Transplant, 2013, 28(3): 689-697.
[13]
Castano E, Palmer MB, Vigneault C. Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome [J]. BMC Nephrol, 2015, 16: 64.
[14]
林峥,林春,江辉,等. 195例淀粉样变性肾病临床病理学相关因素分析 [J]. 湖北医药学院学报,2016, 35(6): 561-565.
[1] 王雪菲, 海琳悦, 李立方, 肖春花. Luminal A型乳腺癌的内分泌治疗与化疗[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 294-300.
[2] 康一坤, 袁芃. 三阴性乳腺癌分子遗传学及临床特征研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 290-293.
[3] 娄丽丽, 刘瀚旻. 儿童哮喘易感基因及表观遗传学研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 249-255.
[4] 刘化胜, 王洪霞, 马正, 王磊. 1例复杂的A3型甲状旁腺腺瘤功能亢进的手术治疗[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 705-706.
[5] 范伟强, 林师佈, 孙传伟, 宋奇锋, 李望, 符誉, 陈艾. 不同切除范围的Bismuth-Corlette Ⅲ、Ⅳ型腹腔镜肝门部胆管癌手术临床对比分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(04): 423-426.
[6] 季瑞冬, 卢振权, 罗兵锋, 侯健, 董汝男, 廖苏才, 罗光彦, 梁伟, 张可可, 郭敏姗, 卢捷娜, 吴旻, 杨伟洪. 无创诊断方法在原发性醛固酮增多症分型诊断中的应用及研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(02): 186-191.
[7] 王建奇, 陈政良, 刘雨, 俞星新, 耿志达, 姜洪池, 梁英健. 基于160例患者CT三维重建的肝血管解剖变异分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 427-433.
[8] 张东, 耿智敏, 全志伟. 胆囊癌临床分型研究现状及进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 147-152.
[9] 付佳禄, 张景玮, 金哲川, 张东, 耿智敏. 胆囊癌临床分型的合理性及其与预后关系——单中心486例分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(02): 173-178.
[10] 胡建生, 周佐霖, 孙林梅, 马腾辉. 不同诊断分型的慢性放射性直肠损伤临床治疗转归:85例回顾性分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 466-472.
[11] 吴晓明, 张蕾, 东靖明. "筋骨并重",关注锁骨远端骨韧带复合体整体诊断和治疗[J]. 中华肩肘外科电子杂志, 2023, 11(02): 97-102.
[12] 秦毓, 杨苗, 畅锴, 王舒宁. 山西省女性人乳头瘤病毒感染现状分析[J]. 中华临床实验室管理电子杂志, 2023, 11(02): 105-108.
[13] 张晓彬, 刘迎娣, 王娟, 孙国辉, 钟立森, 何占娣, 令狐恩强. 孤立性胃静脉曲张临床诊疗经验[J]. 中华胃肠内镜电子杂志, 2023, 10(03): 167-172.
[14] 易和强, 邓志刚. 13例化脓性肋软骨炎的诊治体会[J]. 中华胸部外科电子杂志, 2023, 10(03): 176-179.
[15] 周志明, 姜威, 王泽学, 曲博, 梁磊, 张敏. 肋弓骨折手术内固定治疗[J]. 中华胸部外科电子杂志, 2023, 10(02): 63-69.
阅读次数
全文


摘要